Exploring the genetic and epigenetic factors in cholangiocarcinoma and the latest advancements in immunotherapy treatments.
Exploring how extracellular vesicle PD-L1 helps tumors evade immune detection and emerging therapeutic strategies targeting this mechanism.
Breakthrough advances in radiation therapy for head and neck cancers from ASCO and ESMO 2022, focusing on precision, immunotherapy, and molecular targets.